Sort
40,608 grants matching “prostate cancer”
Applied Biosystems 4800 MALDI TOF/TOF Mass Spectrometer
$412,250Haining Zhu · University Of Kentucky · S10 · FY2007 · RR
Hormone signaling and translation control in advanced prostate cancer
$412,243Andrew Caleb Hsieh · Fred Hutchinson Cancer Center · R37 · FY2024 · CA
Core C: Pathology, Biospecimen and Immune Profiling
$412,236Tamara Levin Lotan · University Of Southern California · U19 · FY2020 · CA
STRUCTURE AND FUNCTION OF THE SPLICE VARIANTS OF TMPRSS2-ERG, A PREVALENT GENOMIC ALTERATION IN PROSTATE CANCER
$412,198The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2008 · Department of Defense
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
$412,108Eric Collisson · University Of California, San Francisco · R01 · FY2021 · CA
Functional Roles of Human Cytochrome P450 Enzymes
$412,100F Peter Guengerich · Vanderbilt University · R35 · FY2025 · GM
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers
$412,090Richard B Silverman · Northwestern University · R01 · FY2021 · CA
Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer
$412,055James M Larner · University Of Virginia · R01 · FY2017 · CA
Image-guided IMRT and Brachytherapy for Pelvic Tumors
$412,005Jeffrey F Williamson · Virginia Commonwealth University · P01 · FY2007 · CA
Recombinational Mechanisms of DNA Repair
$412,000Wolf-Dietrich Heyer · University Of California At Davis · R01 · FY2023 · GM
Metabolic Imaging of the Prostate Using 3D MRSI
$411,989University Of California San Francisco · R01 · FY2002 · CA
Real-time monitoring of circulating pancreatic tumor cells and clusters
$411,981Erica Carpenter · University Of Pennsylvania · R01 · FY2019 · CA
Analysis of epithelial heterogeneity in prostate development and cancer
$411,942Michael M. Shen · Columbia University Health Sciences · R01 · FY2023 · CA
Technology for Optimizing Population Care in a Resource-limited Environment
$411,906Steven J Atlas · Massachusetts General Hospital · R18 · FY2010 · HS
GPCR - Linked RhoGEFs in Tumor Growth and Metastasis
$411,883John J G Tesmer · Purdue University · R01 · FY2018 · CA
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$411,872Deborah V Novack · Ohio State University · P01 · FY2024 · CA
Stromal senescence in lethal prostate cancer: a novel target for prognosis and therapy
$411,778Elizabeth A. Platz · Johns Hopkins University · R01 · FY2023 · CA
Stromal senescence in lethal prostate cancer: a novel target for prognosis and therapy
$411,778Elizabeth A. Platz · Johns Hopkins University · R01 · FY2022 · CA
Clinical Fellowship Training Program
$411,774Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2012 · CA
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
$411,737Ming Hui Chen · Duke University · R01 · FY2023 · CA
Novel Degraders of the Androgen Receptor (AR) and AR Splice Variants (AR-SVs)
$411,723Ramesh Narayanan · University Of Tennessee Health Sci Ctr · R01 · FY2020 · CA
Macro-vasculature: A Novel Image Biomarker of Lung Cance
$411,709Jiantao Pu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
MECHANISMS AND THERAPEUTIC TARGETING OF NSD2 IN ADVANCED PROSTATE CANCER
$411,702Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell · · FY2018 · Defense Health Agency
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER
$411,680Sidney Kimmel Cancer Center · R01 · FY2001 · CA
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER
$411,680Sidney Kimmel Cancer Center · R01 · FY2002 · CA